Loading…
← CockpitCompetitor Analysis › 1336.HK New China Life Insurance Co., Ltd. Class HOpen in the cockpit ↗

New China Life Insurance Co., Ltd. Class H1336.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Financials›Multi-Line Insurance

China-focused, pure-play life and health insurer distributing through agents and bank partnerships.

≈ A pure-play Chinese life insurerMomentum weak 33
Mkt cap
$21.5B
US dollars, full cap
Free float
94%
of shares outstanding
$/day
$41.0M
20-day average traded
P/B
0.87×
price to book
ROE
42.3%
delivered
Implied ROE
10.3%
what the price asks
Next earnings
146 days
1 Apr 2027
Close · HKDHK$39.86
1D-1.4%
1W+2.6%
1M-9.9%
3M-17.8%
6M-24.2%
YTD-26.7%
1Y-21.1%
ATR %3.2%
52w lowhigh39.4% off high

What New China Life Insurance does

China-focused, pure-play life and health insurer distributing through agents and bank partnerships.

Collects premiums on long-term life, health and savings policies and invests the money until benefits are due, so investment income matters alongside underwriting. Agents and bank branches sell the policies. This is the Hong Kong-listed share class of the Shanghai-listed company, with the state investment arm Central Huijin as largest shareholder.

In one line: A pure-play Chinese life insurer.

Products and services

  • Life insurance
  • Health insurance
  • Annuity/pension products

Customers

  • Retail policyholders in China

Where it sits in the supply chain

  • Financials
  • Insurance
  • Life & health insurance

What could go right

  • Life premium growth (protection gap)
  • Investment income recovery

What could go wrong

  • Interest-rate/investment-return risk
  • Agent-channel productivity decline

Moat: narrow (brand, distribution). Established agent and bancassurance distribution network, without P&C diversification.

Headquarters: Beijing, China · Founded: 1996 · Employees: 27,726

Named competitors

New China Life Insurance at a glance

Size New China Life Insurance (1336.HK) is a Hong Kong Financials company (Multi-Line Insurance) with a market value of $21.5B, the 80th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$39.86 on 6 Nov 2026.

Performance Over six months the shares fell 24.2%, against +11.3% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue grew 44.4% over the last twelve months (peer median +6.5%); the operating margin is 31.2% (peer median 9.4%).

Valuation It trades at 0.87× book value against a peer median of 1.68× (2nd cheapest of 21).

Price implies The share price implies a return on equity of about 10.3%; New China Life Insurance delivers 42.3%, so the price asks less than the business earns today.

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 1121336.HK 75
Six months, rebased to 100: New China Life Insurance against the median of its 20 peers (local-currency closes).

New China Life Insurance financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$180BHK$146BHK$105BHK$108BHK$149B
Revenue growth—+39%-3%-27%—
Net incomeHK$49.5BHK$39.4BHK$28.4BHK$9.63BHK$25.0B
Free cash flowHK$180BHK$170BHK$150BHK$143BHK$149B
Capital expenditureHK$1.61BHK$1.61BHK$1.19BHK$2.31BHK$2.08B
Total debtn/aHK$239BHK$216BHK$141BHK$61.2B

Quarterly statements and history in the cockpit →

New China Life Insurance competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%LGENUNIASRNLHBANWRBCINFPZUAV2378BNTSUNGJFPUKMAPCNAAGNACGLUNMGL1336.HK6-month return →1-month return →
Up and to the right = strong over both horizons. New China Life Insurance is the large dot.

Fundamentals: return on equity against price-to-book

10%20%30%40%20×40×60×LGENUNIASRNLHBANWRBCINFPZUAV2378BNTSUNGJFMAPCNAUNMGL86301336.HKReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. New China Life Insurance is the large dot.

Capital: ROE delivered against the ROE the price implies

0%20%40%60%0%20%40%60%LGENUNIASRNLHBANCINFPZUAV2378BNTSUNGJFCNA1336.HKROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. New China Life Insurance is the large dot.

New China Life Insurance competitors and peer comparison

Head to head with its named competitors (1336.HK vs 2601.HK vs 2628.HK vs 2318.HK)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
New China Life Insurance 1336.HK$21.5B-24%+44%42%0.87×10.3%
China Pacific Insurance (Group) 2601.HK$42.5B-22%+9%14%0.69×8.4%
China Life 2628.HK$134B-17%+38%41%0.93×10.0%
Ping An 2318.HK$138B-17%-8%10%0.79×9.7%
China Taiping Insurance 0966.HK$8.28B-24%+19%36%0.63×8.1%

How New China Life Insurance compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

New China Life Insurance against its 20 peers (data as of 6 Nov 2026)
Measure1336.HKPeer medianRank in peer set
1-month return-9.9%+4.0%2nd lowest of 21
6-month return-24.2%+11.3%lowest of 21
Return on equity42.3%15.7%highest of 21
Price / book0.87×1.68×2nd cheapest of 21
Trailing P/E2.5×11.7×cheapest of 20
ROE the price implies10.3%10.9%10th least demanding of 21
ROE delivered42.3%14.6%highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
New China Life Insurance 1336.HKHong Kong$21.5B-24%+44%42%0.87×10.3%42.3%
Legal & General LGEN.LUnited Kingdom$21.9B+24%+137%26%7.73×70.7%26.2%
Unipol Assicurazioni UNI.MIItaly$23.8B+13%+7%17%1.62×14.9%16.9%
ASR Nederland ASRNL.ASNetherlands$17.3B+14%+6%13%1.74×8.3%13.1%
Helvetia Baloise HBAN.SWSwitzerland$27.0B+5%+54%4%1.80×4.8%4.0%
W. R. Berkley WRBUnited States$27.9B+16%+1%19%2.91×12.8%19.2%
Cincinnati Financial CINFUnited States$28.5B+15%+10%17%1.76×10.6%16.9%
Powszechny Zaklad Ubezpieczen Spolka Akcyjna PZU.WAPoland$16.1B+15%+1%20%1.83×19.5%19.5%
Aviva AV..LUnited Kingdom$29.5B+18%+86%7%2.46×23.8%6.8%
Prudential 2378.HKHong Kong$30.8B-24%+30%19%1.54×11.3%19.3%
Brookfield Wealth Solutions BNT.TOCanada$14.9B-8%-18%1%0.70×9.4%0.7%
Suncorp SUN.AXAustralia$14.9B+21%-3%10%2.08×11.7%9.8%
Gjensidige Forsikring GJF.OLNorway$14.7B+9%+7%30%5.73×19.1%29.9%
Prudential plc Sponsored ADR PUKUnited States$31.7B-21%+39%19%1.56×11.4%19.2%
Mapfre MAP.MCSpain$14.1B-2%+5%12%1.26×8.4%12.4%
CNA Financial CNAUnited States$12.8B+9%+2%10%1.25×7.2%9.6%
Aegon AGN.ASNetherlands$12.7B+4%+16%10%1.25×8.2%10.5%
Arch Capital ACGLUnited States$36.6B+14%-5%19%1.58×8.3%18.7%
Unum UNMUnited States$12.2B-5%-5%3%1.52×8.1%2.6%
Globe Life GLUnited States$12.1B+4%+6%21%2.08×11.7%n/a
Sompo 8630.TJapan$39.6B+17%+41%15%1.14×6.2%14.6%

Questions

Who are New China Life Insurance's main competitors?
Named competitors: China Pacific Insurance (2601.HK), China Life Insurance (2628.HK), Ping An Insurance (2318.HK), China Taiping Insurance (0966.HK). The cockpit's measured peer set (industry) also includes Legal & General (LGEN.L), Unipol Assicurazioni (UNI.MI), ASR Nederland (ASRNL.AS), Helvetia Baloise (HBAN.SW), W. R. Berkley (WRB), Cincinnati Financial (CINF).
Is New China Life Insurance expensive compared with its peers?
On price / book it trades at 0.87× against a peer median of 1.68×, 2nd cheapest of 21 in its peer set. The share price implies a return on equity of about 10.3%; New China Life Insurance delivers 42.3%, so the price asks less than the business earns today.
How has New China Life Insurance stock performed?
Over six months to 6 Nov 2026 the shares returned -24.2% against +11.3% for the median peer; over one year -21.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.